Pfizer Agrees To Shell Out $50M To Exit EpiPen Antitrust Suit

By Hailey Konnath (October 10, 2023, 11:19 PM EDT) -- Pfizer Inc. has agreed to pay $50 million to put to rest allegations it and Mylan Pharmaceuticals conspired to inflate the price of emergency allergy medication, an agreement that wraps up years of litigation and months of negotiations, according to a motion filed in Kansas federal court on Tuesday....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!